Libertas Bio
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on Libertas Bio
Scrip
• By Mandy Jackson
Biopharmaceutical venture capital fundraising is on the rise in 2024, boosted in part by surging numbers of $100m-plus mega-rounds, including a pair of large financings that ended June and started Jul
Scrip
• By Alaric DeArment
LEO Pharma A/S has hit the mark a second time in a clinical trial program meant to expand its competitive positioning in dermatology with the news that a second Phase III study of its topical JAK inh